BioSpace News Archive

Business

Tonix Pharmaceuticals Appoints Jessica Morris as COO

Ms. Morris brings to the senior leadership team a deep understanding of drug development and corporate strategy from her tenure at Tonix as well as over a decade of experience in the financial industry.

January 9, 2018
·
3 min read
Prevent Biometrics Announces Commercial Launch of Head Impact Monitor System, Bringing Advanced Real-Time Monitoring of Concussion Impacts to Sports

Prevent Biometrics announces its newest innovation at the Consumer Electronics Show today: the Gen 1.2 Head Impact Monitor System.

January 9, 2018
·
4 min read
Business

Kelyniam Global Names a New CEO

The company has also appointed Mark V. Smith, MD., as Vice President of Sales and Business Development.

January 9, 2018
·
3 min read
Business

Robert J. Meyer, M.D. Joins Greenleaf Health

Greenleaf Health today announces that Robert (Bob) Meyer, M.D. has joined the firm as Principal, Drug and Biological Products.

January 9, 2018
·
4 min read
Business

Bay Area’s BioClin Taps Gilead R&D Exec as New CMO

This build out of the executive team follows the closing of a $30 million Series B financing announced last year.

January 9, 2018
·
4 min read
Genetown

USPTO Grants Glytec Patent Allowance for Computer-Guided Selection and Dosing of All Diabetes Medications

The patent allowance, issued by the United States Patent and Trademark Office, comprises an intricate series of 24 claims that describe personalized computer-guided selection and dosing of any prescribed diabetes therapy regimen, whether insulin only, non-insulin only or combination.

January 9, 2018
·
4 min read
Biotech Beach

New App-Driven Device from Oska Pulse: “Oska Pulse Active”

Oska Pulse Active App and device will be available to consumers Spring, 2018.

January 9, 2018
·
5 min read
ESSA Completes $21M Equity Offering

Pursuant to the Concurrent Private Placement, the Company issued 3,375,000 Common Shares at the Offering Price to certain directors of the Company for additional aggregate gross proceeds of US$675,000.

January 9, 2018
·
6 min read
Business

Genetic Technologies Regains Nasdaq Listing Compliance

The Notice confirms that the Nasdaq Listing Rules deficiency notice of July 19, 2017, has been remedied and that the matter is now closed.

January 9, 2018
·
2 min read
Pharm Country

Oncoceutics Extends IP Coverage to Japan With New Patent Covering All Cancers

Oncoceutics announced that the Japanese Patent Office has issued Japanese Patent No. 6132833 for the use of ONC201 to treat all cancers or patients having a risk of cancer, including brain, colon, breast, colorectal cancers, and glioblastoma.

January 9, 2018
·
2 min read